Roundup

On August 10, 2018, a California jury ruled that Monsanto’s Roundup and Ranger Pro herbicides contributed to a school groundskeeper’s lymphoma and slapped the company with a combined $289 million in compensatory and punitive damages in a landmark suit against the agricultural giant, which has denied links between its herbicides and cancer for decades.

 

Monsanto’s Roundup weed killer (herbicide) has been designated as a probable human carcinogen by the World Health Organization. Farm workers, landscapers, gardeners and others who use Roundup are at risk for developing non-Hodgkin lymphoma and other forms of cancer. Consumers in the United States who have been diagnosed with cancer due to Roundup herbicide are filing lawsuits again Monsanto in state and federal court.

 

Mark P. Robinson, Jr. and his firm, Robinson Calcagnie, Inc., have filed Roundup lawsuits and are currently investigating potential claims against Monsanto on behalf of Roundup-users who developed non-Hodgkin Lymphoma.  If you or a loved one have been diagnosed with non-Hodgkin lymphoma after being exposed to Roundup weed killer, you may be eligible to file a claim.  Contact us for a free and confidential evaluation of your case. We can help you understand your rights and answer any questions you may have.

Contact us today

To all current and prospective clients, please be advised that while we are open for business and working remotely, effective Tuesday March 17th, our offices will be closed to the public. All of our attorneys will continue to advocate for their clients and are available via telephone, email/or videoconference. Our receptionist will continue to answer the phone and connect you with our attorneys and staff as needed. To our prospective clients, we are here for you to answer questions and to consult with free of charge as usual. Consultations can be conducted by telephone or videoconference. We hope everyone and their families are safe and sound during this unusual time. Please call or email us with any questions or concerns. Thank you! Close